Perrigo Co PLC (PRGO)

Add to Watchlists
Create an Alert
46.18 +0.51  +1.12% NYSE Aug 16, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/08/2019 08:30 EST Misc Perrigo Co PLC Third Quarter Earnings Conference Call in 2019
11/08/2019 Earnings Perrigo Co PLC Third Quarter Earnings in 2019 Release
08/29/2019 Dividends Amount: 0.21, Declared Date: Jul 31 2019, Pay Date: Sep 17 2019
08/08/2019 08:00 EDT Misc Perrigo Co PLC Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Perrigo Co PLC Second Quarter Earnings in 2019 Release
05/30/2019 Dividends Amount: 0.21, Declared Date: Apr 26 2019, Pay Date: Jun 18 2019
05/09/2019 08:00 EDT Misc Perrigo Co PLC First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Perrigo Co PLC First Quarter Earnings in 2019 Release
04/26/2019 10:00 GMT Misc Perrigo Co PLC Annual General Meeting in 2018
02/28/2019 Dividends Amount: 0.19, Declared Date: Feb 14 2019, Pay Date: Mar 19 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.perrigo.com
  • Investor Relations URL: http://perrigo.investorroom.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Nov. 08, 2019
  • Last Earnings Release: Aug. 08, 2019
  • Next Ex-Dividend Date: Aug. 29, 2019
  • Last Ex-Dividend Date: May. 30, 2019
  • Description: Perrigo is the largest store-brand over-the-counter pharmaceutical and infant formula manufacturer. The company operates three major segments: consumer healthcare, branded consumer healthcare, and prescription pharmaceuticals. As of mid-2018, Perrigo plans to divest the prescription segment. In the United States, Perrigo sells about 2,100 products with 9,000 stock-keeping units. Following the acquisition of Omega Pharma, approximately 30% of the company’s revenue comes from outside the U.S.

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.98%
PARWX Parnassus Endeavor Investor 4.40%
UTRN Vesper US Large Cap S-T Rvrsl Stgy ETF 4.00%
IHE iShares US Pharmaceuticals ETF 2.73%
EAFRX First Eagle Fund of America R4 2.68%
PPH VanEck Vectors Pharmaceutical ETF 2.56%
FTXH First Trust Nasdaq Pharmaceuticals ETF 1.87%
RYH Invesco S&P 500® Equal Wt Hlth Care ETF 1.72%
RRMVX T. Rowe Price Mid-Cap Value R 1.70%
JMVNX JHFunds2 Mid Value NAV 1.53%
FMQSX Franklin Mutual Quest R 1.48%
DTMVX DFA Tax-Managed US Targeted Value 0.42%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("PRGO","name")
  • Description: =YCI("PRGO","description")
  • Sector: =YCI("PRGO","sector")
  • Industry: =YCI("PRGO","industry")
  • Est. Current Fiscal Year End: =YCI("PRGO","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.